Matches in Wikidata for { <http://www.wikidata.org/entity/Q63598690> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q63598690 description "clinical trial" @default.
- Q63598690 description "ensayu clínicu" @default.
- Q63598690 description "klinisch onderzoek" @default.
- Q63598690 description "клінічне випробування" @default.
- Q63598690 description "կլինիկական փորձարկում" @default.
- Q63598690 name "REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)" @default.
- Q63598690 type Item @default.
- Q63598690 label "REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)" @default.
- Q63598690 prefLabel "REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)" @default.
- Q63598690 P1050 Q63598690-96CA9521-13F5-43EA-842D-707C146475CE @default.
- Q63598690 P1132 Q63598690-FDF972EE-CFB4-474D-B5A0-8ECE45B28BE3 @default.
- Q63598690 P131 Q63598690-F8D13E36-99C8-45D8-B72B-AE14C709509C @default.
- Q63598690 P1476 Q63598690-A91B21CB-0E1E-4576-B4AB-C9D6B3B008E1 @default.
- Q63598690 P17 Q63598690-C5946483-A2F0-4631-896B-0327C9F491F8 @default.
- Q63598690 P2899 Q63598690-006740F0-9AE1-4743-8EC2-291F6AF7897C @default.
- Q63598690 P3098 Q63598690-6EAF0AC3-C375-4EE0-80BA-1645D7AB5F02 @default.
- Q63598690 P31 Q63598690-DFDD4F22-DB30-4051-A8F6-AA2DEC95FDEE @default.
- Q63598690 P580 Q63598690-AB402AA4-9445-47A1-A927-98CE71D51C3D @default.
- Q63598690 P582 Q63598690-9F67DC8B-4C46-42F4-8F82-D40F106E8540 @default.
- Q63598690 P6099 Q63598690-7E0117C2-30CD-488E-ADA4-5B60AE232B6A @default.
- Q63598690 P6153 Q63598690-273C9A36-348F-4FA5-82B2-CDD9200143C7 @default.
- Q63598690 P6153 Q63598690-431A21EC-75ED-4475-B181-35EF7643AC37 @default.
- Q63598690 P6153 Q63598690-66496BD4-CDC4-4122-9AF7-BEBA558C4384 @default.
- Q63598690 P6153 Q63598690-8538A3B0-8409-4C86-B5AB-2F396341C980 @default.
- Q63598690 P6153 Q63598690-A5EDF1D5-6982-4C32-8E68-0184F70CDBBC @default.
- Q63598690 P6153 Q63598690-B3638EC6-C9AC-4875-8DFF-73862818B2E0 @default.
- Q63598690 P6153 Q63598690-B91BC825-49EC-4525-8213-33BC68BCA77B @default.
- Q63598690 P6153 Q63598690-EBFB5557-F771-4E39-8D62-FE8D33192F6A @default.
- Q63598690 P6153 Q63598690-FDF8E736-5E78-44B3-95AF-F85ACFC600FB @default.
- Q63598690 P8363 Q63598690-E6D3EC06-2D92-48E1-9E67-518A15849DDB @default.
- Q63598690 P1050 Q196788 @default.
- Q63598690 P1132 "+198" @default.
- Q63598690 P131 Q1183 @default.
- Q63598690 P1476 "Reveal 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix" @default.
- Q63598690 P17 Q30 @default.
- Q63598690 P2899 "+18" @default.
- Q63598690 P3098 "NCT03721978" @default.
- Q63598690 P31 Q30612 @default.
- Q63598690 P580 "2019-04-02T00:00:00Z" @default.
- Q63598690 P582 "2021-04-30T00:00:00Z" @default.
- Q63598690 P6099 Q42824827 @default.
- Q63598690 P6153 Q1134710 @default.
- Q63598690 P6153 Q2415975 @default.
- Q63598690 P6153 Q29480370 @default.
- Q63598690 P6153 Q30298962 @default.
- Q63598690 P6153 Q5547686 @default.
- Q63598690 P6153 Q5902531 @default.
- Q63598690 P6153 Q6905066 @default.
- Q63598690 P6153 Q7009262 @default.
- Q63598690 P6153 Q924265 @default.
- Q63598690 P8363 Q78089383 @default.